Track the evolution of major financial and economic events
WEC Energy reported mixed Q2 2026 results, with earnings per share of $0.91 beating estimates despite a revenue miss, driven by rate base growth and infrastructure gains. Verisk Analytics exceeded both revenue and earnings expectations while providing full-year 2026 guidance. Additionally, Exelon met earnings estimates as its revenue rose 10% following utility rate increases.
Amphenol reported record second-quarter sales with a 55% increase, fueled by exceptional organic growth in the IT datacom market. Meanwhile, CBIZ's net income dropped by 55.6% to $19 million for the second quarter of 2026. Additionally, Viasat scheduled the release of its first-quarter fiscal year 2027 financial results for August 4, 2026.
SoFi Technologies raised its 2026 revenue guidance following record member growth and loan originations in the second quarter. The company reported 40-41% year-over-year revenue growth, marking its 11th consecutive profitable quarter. Fee-based revenue now accounts for 39% of total revenue, reinforcing its 'everything app' strategy. Despite the strong performance, SoFi issued conservative guidance for the remainder of the year, anticipating potential Federal Reserve rate hikes.
VF Corporation reported first quarter fiscal 2027 results that exceeded its previous guidance, leading the company to raise its full-year revenue outlook. Additionally, Valero Energy reported a significant Q2 net income of $3.7 billion, up from $714 million the previous year. Vertiv also raised its 2026 outlook driven by robust demand for data center infrastructure.
Between July 29 and 30, 2026, several major companies reported their second-quarter financial results, highlighted by Avantor exceeding expectations with $1,692.3 million in sales and raising its full-year guidance. Conversely, ArcBest reported a net loss of $13.8 million despite generating $1.2 billion in revenue. Additionally, BMY, VRT, and EME all beat earnings estimates, with BMY and VRT raising their financial outlooks, while EME achieved record revenues and a record backlog driven by broad-based growth.
Major corporations reported strong earnings for the first half of 2026, led by UBS Group and Reckitt Benckiser. UBS posted a Q2 net profit of $2.8 billion, driven by growth in wealth management and investment banking, and announced a $3 billion share buyback program. Reckitt reported accelerating sales growth, while The Weir Group saw increased orders fueled by mining activity in copper and gold. Despite the positive results, Morgan Stanley maintained an 'Underweight' rating on UBS while raising its price target to CHF 40.
BASF reported a sharp rise in second-quarter earnings, driven by higher prices and volume growth. Following these strong quarterly results, the chemical group raised its full-year EBITDA outlook. Additionally, Befesa reported an 11% increase in its first-half adjusted EBITDA, reaching €124 million.
Procter & Gamble and Ford exceeded earnings expectations, while Mondelez raised its financial guidance following strong performance. Despite these results, U.S. stock futures traded lower as investors awaited earnings from major firms like Microsoft. Additionally, PPG Industries reported its sixth consecutive quarter of organic growth, and PennyMac Financial Services posted a $22 million net income amid interest-rate volatility. Finally, P&G reported results within its guidance and returned over $15 billion to its shareholders.
SK Hynix achieved a record 557% surge in Q2 profits fueled by AI memory chip demand, yet failed to meet analyst expectations for revenue and profit. The company's stock initially cratered following the announcement of a $31 billion capital expenditure plan. By July 31, shares rebounded significantly, surging over 20% alongside a rally in U.S. tech stocks and the iShares Semiconductor ETF (SOXX).
Camden National (CAC) reported record second-quarter 2026 earnings with a diluted EPS of $1.35, surpassing analyst expectations. On July 28, Larsen & Toubro conducted its first-quarter 2027 earnings call following the release of its financial results. Additionally, several companies including Centene and Kilroy Realty released transcripts for their respective second-quarter 2026 earnings calls.
BlackRock integrated HPS Investment Partners and launched the Private Financing Solutions unit to strengthen its position in the private credit sector. Following this, BlackRock TCP Capital transferred $523 million in debt investments, nearly half of its portfolio, to a new fund backed by Pantheon Ventures. Meanwhile, Jefferies obtained new evidence regarding fake invoices involving a troubled investment fund. The firm continues to evaluate further drastic strategic moves to navigate the evolving market landscape.
NXP Semiconductors reported a second-quarter profit of $767 million for 2026, driven by robust demand across all regions and end markets. Growth was particularly strong in the software-defined vehicles and physical AI sectors. Additionally, recent reports indicate that the company is in discussions to acquire chip designer Ambarella.
Bloom Energy shares surged after reporting second-quarter 2026 financial results that exceeded analyst estimates. The company delivered 166% year-over-year revenue growth and expanded its non-GAAP operating margin to 22.5%. Consequently, Bloom Energy raised its 2026 guidance, targeting over $4 billion in revenue and $800–900 million in operating income. Growth is further supported by expanded financing partnerships, including a $25 billion commitment from Brookfield.
In late July 2026, several major companies reported strong financial results driven by AI demand and infrastructure growth. FMX saw a significant 64.9% jump in net income, while Corning exceeded expectations due to AI data center needs and DTE Energy remained on track for its high-end full-year guidance. Additionally, TechnipFMC and GFL Environmental reported robust performance, with the latter raising its outlook for the second time. Despite challenges like high fuel prices and geopolitical disruptions, IAG maintained a resilient performance throughout the first half of the year.
Meta and BlackRock have entered a $14 billion strategic partnership to develop a massive AI data center in Texas to support growing processing needs. Meta subsequently disclosed that its future lease obligations for AI infrastructure surged 53% in three months, reaching $279 billion. Additionally, the company expanded its AI portfolio by launching 'Muse Code,' a coding agent designed to compete with rivals Anthropic and OpenAI.
Boeing reported a wider-than-expected loss for the second quarter, primarily driven by a $280 million charge related to its Air Force One replacement program. Despite the loss, revenue grew 8% year-over-year to $24.6 billion, exceeding analyst estimates, and the company generated positive free cash flow. Additionally, Boeing's order backlog reached a new record high of $715 billion, signaling momentum in its strategic turnaround plans.
Coca-Cola reported a 7% increase in net revenues for the second quarter of 2026, soundly exceeding analyst expectations. Driven by volume growth, a tax rate cut, and increased demand from the World Cup, the company raised its earnings per share (EPS) guidance for 2026. These strong results led to an upward revision of its forward-looking financial outlook.
Corning reported a 17% year-over-year increase in core sales to $4.74 billion for the second quarter of 2026, with earnings per share rising 30% to $0.78. The Optical Communications segment saw significant growth of 32% due to high demand for Generative AI infrastructure. Despite beating estimates, GLW stock fell 12% to $122.92 in premarket trading following the issuance of soft guidance. This decline brought the stock to its lowest level since March 9 of this year.
Amkor Technology reported record second-quarter results, with earnings and revenue significantly exceeding analyst expectations. This performance was primarily driven by robust demand for AI data center technologies. However, despite the strong quarterly results, the company's stock price experienced a sharp decline following future revenue guidance that failed to meet analyst estimates.
Capricor Therapeutics shares plummeted 67.7% following market warning signs and a negative vote from a U.S. FDA expert panel. The panel rejected effectiveness data for the company's cell therapy targeting Duchenne muscular dystrophy-related heart conditions. Consequently, law firms initiated investigations into potential federal securities law violations following reports of a failed Phase 3 trial. These developments led to a further 60% drop in premarket trading on July 30.
Bank of Hawai‘i reported a net income of $63.8 million for Q2 2026, an 11.1% increase from the linked quarter, with diluted earnings per share of $1.47. The bank's performance beat estimates driven by strong net interest income and loan growth, while return on average common equity rose to 15.47%. Despite these positive results, share prices fell 4.7% following reports of declining fee income and deposit balances.
AstraZeneca announced on July 27 that its drug Ultomiris failed to meet the primary goal in a late-stage clinical trial for patients with blood vessel complications. On August 2, the Financial Times reported that the company had recently held merger discussions with Bristol Myers Squibb. These events outline a period of clinical setbacks and strategic exploration for the pharmaceutical giant.
AstraZeneca exceeded second-quarter profit expectations on July 27, driven by strong demand for cancer and heart disease therapies. The company reaffirmed its 2026 financial outlook to ease investor concerns following a recent clinical trial failure. However, shares declined on August 3 amid reports of potential merger discussions with Bristol Myers Squibb. This decline could mark the stock's largest one-day percentage drop since the 2024 U.S. presidential election.
Shein reported an unexpected quarterly loss as it prepares for its initial public offering in Hong Kong, leading the company to consider a valuation reset for late-stage investors. Growth and profitability have been negatively impacted by new U.S. tariffs and the removal of the de minimis exemption. Furthermore, the company anticipates further sales declines in Europe, its largest market, due to similar upcoming regulatory changes.
